Café

© 2026 Longbridge｜Terms of Service Privacy Policy

BeOne Medicine shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $333 to $380.

BeOne Medicine shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $333 to $380.

benzinga_article

Jul 13, 2026 at 06:38 AM

BeOne Medicine shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $333 to $380.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Beigene

USONC

+1.44%

Jefferies Financial

USJEF

LongbridgeAI